Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 4/2015

01-04-2015 | Letter to the Editor

The immunoglobulin isotype matters in diffuse-large-B-cell lymphoma with serum paraproteinaemia

Authors: M. Christina Cox, Arianna Di Napoli, Stefania Scarpino, Luigi Ruco

Published in: Annals of Hematology | Issue 4/2015

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Kim YR, Kim SJ, Cheong JW, Kim Y, Jang JE, Lee JY, Min YH, Song JW, Yang WI, Kim JS.(2014) Monoclonal and polyclonal gammopathy measured by serum free light chain and immunofixation subdivide the clinical outcomes of diffuse large B-celllymphoma according to molecular classification. Ann Hematol. [Epub ahead of print]
2.
Cox MC, Di Napoli A, Scarpino S, Salerno G, Tatarelli C, Talerico C et al (2014) Clinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component. PLoS One 9(4):e93903CrossRefPubMedCentralPubMed
3.
Lenz G, Siebert R, Roschke AV, Sanger W, Wright GW et al (2007) Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. J Exp Med 204(3):633–643CrossRefPubMedCentralPubMed
4.
Ruminy P, Couronné L, Parmentier F, Rainville V, Mareschal S, Bohers E et al (2011) The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma. Leukemia 25(4):681–688CrossRefPubMed
5.
Jardin F, Delfau-Larue MH, Molina TJ, Copie-Bergman C, Briere J, Petrella T et al (2013) Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma. Leuk Lymphoma 54(9):1898–1907CrossRefPubMed
Metadata
Title
The immunoglobulin isotype matters in diffuse-large-B-cell lymphoma with serum paraproteinaemia
Authors
M. Christina Cox
Arianna Di Napoli
Stefania Scarpino
Luigi Ruco
Publication date
01-04-2015
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 4/2015
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-014-2201-2

Other articles of this Issue 4/2015

Annals of Hematology 4/2015 Go to the issue

Original Article

Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation

Letter to the Editor

Severe haemophagocytic lymphohistiocytosis triggered by a visceral leishmaniasis in a patient with a Rosai-Dorfman disease

Original Article

Serum hepcidin-25 level linked with high mortality in patients with non-Hodgkin lymphoma

Letter to the Editor

Activated partial thromboplastin time sensitivity to lupus anticoagulant in a patient with transient arthritis and lupus anticoagulant-hypoprothrombinemia syndrome

Letter to the Editor

Safety and efficacy of ruxolitinib in a profoundly thrombocytopenic patient with myelofibrosis

Letter to the Editor

Cutaneous Langerhans cell sarcoma relapsing systemically: Complete remission with the EPIG regimen
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits